AFNAS
PGNX

American Financial Network Advisory Services’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

American Financial Network Advisory Services’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-220
Closed -$2K – 797
2017
Q3 		$2K Buy
+220
New +$1.4K ﹤0.01% 720

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

American Financial Network Advisory Services's PGNX Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2017, closing a stake of 220 shares — an estimated $2K sold.

American Financial Network Advisory Services first reported a position in PGNX in Q3 2017 and held it in 1 quarter. The position peaked at $2K in Q3 2017. 153 funds tracked by Wall St. Rank hold PGNX as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 220 Progenics Pharmaceuticals Inc shares in Q4 2017, an estimated $2K.
  • American Financial Network Advisory Services first reported a position in Progenics Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's Progenics Pharmaceuticals Inc position peaked at $2K in Q3 2017.
  • 153 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.